Wane

Polymedco announces US FDA clearance of the PATHFAST high-sensitivity cardiac troponin I (hs-cTnI-II) test as an aid in the diagnosis of myocardial infarction

PATHFAST hs-cTnI-II becomes first and only hs-cTn test cleared for point-of-care use in the United States, delivering results up to three times faster than core lab testing CORTLANDT MANOR, N.Y., ...
KELOLAND News

Polymedco Joins CancerX to Accelerate Innovation in Cancer Detection and Diagnosis

CORTLANDT MANOR, N.Y., Jan. 30, 2024 /PRNewswire/ -- Polymedco, a leading provider of best-in-class colorectal cancer screening and early detection solutions, is proud to announce its membership in ...
KXAN

Polymedco Announces: New Published Research Supports Fecal Immunochemical Testing (FIT) as the Most Clinically and Cost Effective Noninvasive Colorectal Cancer Screening (CRC ...

Screening annually with a method like OC-Auto FIT improves outcomes and delivers greater cost-effectiveness. Key findings from the study include: Annual FIT-based screening produced fewer CRC cases, ...
Becker's ASC

Clinical company Polymedco partners with Colon Cancer Prevention Project

Polymedco, a manufacturer, marketer and distributor in the clinical laboratory space, has pledged support to the Colon Cancer Prevention Project, based in Louisville, Ky. Polymedco will lend support ...